These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28557812)

  • 1. Two patients with 19p13.2 deletion (Malan syndrome) involving NFIX and CACNA1A with overgrowth, developmental delay, and epilepsy.
    Kuroda Y; Mizuno Y; Mimaki M; Oka A; Sato Y; Ogawa S; Kurosawa K
    Clin Dysmorphol; 2017 Oct; 26(4):224-227. PubMed ID: 28557812
    [No Abstract]   [Full Text] [Related]  

  • 2. Malan syndrome (Sotos syndrome 2) in two patients with 19p13.2 deletion encompassing NFIX gene and novel NFIX sequence variant.
    Jezela-Stanek A; Kucharczyk M; Falana K; Jurkiewicz D; Mlynek M; Wicher D; Rydzanicz M; Kugaudo M; Cieslikowska A; Ciara E; Ploski R; Krajewska-Walasek M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):161-7. PubMed ID: 26927468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malan syndrome in a patient with 19p13.2p13.12 deletion encompassing NFIX and CACNA1A genes: Case report and review of the literature.
    Bellucco FT; de Mello CB; Meloni VA; Melaragno MI
    Mol Genet Genomic Med; 2019 Dec; 7(12):e997. PubMed ID: 31574590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further delineation of Malan syndrome.
    Priolo M; Schanze D; Tatton-Brown K; Mulder PA; Tenorio J; Kooblall K; Acero IH; Alkuraya FS; Arias P; Bernardini L; Bijlsma EK; Cole T; Coubes C; Dapia I; Davies S; Di Donato N; Elcioglu NH; Fahrner JA; Foster A; González NG; Huber I; Iascone M; Kaiser AS; Kamath A; Liebelt J; Lynch SA; Maas SM; Mammì C; Mathijssen IB; McKee S; Menke LA; Mirzaa GM; Montgomery T; Neubauer D; Neumann TE; Pintomalli L; Pisanti MA; Plomp AS; Price S; Salter C; Santos-Simarro F; Sarda P; Segovia M; Shaw-Smith C; Smithson S; Suri M; Valdez RM; Van Haeringen A; Van Hagen JM; Zollino M; Lapunzina P; Thakker RV; Zenker M; Hennekam RC
    Hum Mutat; 2018 Sep; 39(9):1226-1237. PubMed ID: 29897170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An association of 19p13.2 microdeletions with Malan syndrome and Chiari malformation.
    Shimojima K; Okamoto N; Tamasaki A; Sangu N; Shimada S; Yamamoto T
    Am J Med Genet A; 2015 Apr; 167A(4):724-30. PubMed ID: 25736188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NFIX mutations affecting the DNA-binding domain cause a peculiar overgrowth syndrome (Malan syndrome): a new patients series.
    Gurrieri F; Cavaliere ML; Wischmeijer A; Mammì C; Neri G; Pisanti MA; Rodella G; Laganà C; Priolo M
    Eur J Med Genet; 2015 Sep; 58(9):488-91. PubMed ID: 26193383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 19p13 microduplications encompassing NFIX are responsible for intellectual disability, short stature and small head circumference.
    Trimouille A; Houcinat N; Vuillaume ML; Fergelot P; Boucher C; Toutain J; Caignec CL; Vincent M; Nizon M; Andrieux J; Vanlerberghe C; Delobel B; Duban B; Mansour S; Baple E; McKeown C; Poke G; Robertshaw K; Fifield E; Fabretto A; Pecile V; Gasparini P; Carrozzi M; Lacombe D; Arveiler B; Rooryck C; Moutton S
    Eur J Hum Genet; 2018 Jan; 26(1):85-93. PubMed ID: 29184170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Array-CGH detection of a de novo 0.7-Mb deletion in 19p13.13 including CACNA1A associated with mental retardation and epilepsy with infantile spasms.
    Auvin S; Holder-Espinasse M; Lamblin MD; Andrieux J
    Epilepsia; 2009 Nov; 50(11):2501-3. PubMed ID: 19874387
    [No Abstract]   [Full Text] [Related]  

  • 9. [Microdeletion 2q23.1 and syndromic findings].
    Pérez-Gay L; Gómez-Lado C; Eirís-Puñal J; Dacruz D; Quintela I; Barros-Angueira F; Castro-Gago M
    Rev Neurol; 2013 Nov; 57(9):430-1. PubMed ID: 24150955
    [No Abstract]   [Full Text] [Related]  

  • 10. Apparent germline mosaicism for a novel 19p13.13 deletion disrupting NFIX and CACNA1A.
    Nimmakayalu M; Horton VK; Darbro B; Patil SR; Alsayouf H; Keppler-Noreuil K; Shchelochkov OA
    Am J Med Genet A; 2013 May; 161A(5):1105-9. PubMed ID: 23495138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intellectual disability and overgrowth-A new case of 19p13.13 microdeletion syndrome with digital abnormalities.
    Jorge R; Silva C; Águeda S; Dória S; Leão M
    Am J Med Genet A; 2015 Nov; 167A(11):2839-43. PubMed ID: 26338046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct effects of allelic NFIX mutations on nonsense-mediated mRNA decay engender either a Sotos-like or a Marshall-Smith syndrome.
    Malan V; Rajan D; Thomas S; Shaw AC; Louis Dit Picard H; Layet V; Till M; van Haeringen A; Mortier G; Nampoothiri S; Puseljić S; Legeai-Mallet L; Carter NP; Vekemans M; Munnich A; Hennekam RC; Colleaux L; Cormier-Daire V
    Am J Hum Genet; 2010 Aug; 87(2):189-98. PubMed ID: 20673863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Branchial arch defects and 19p13.12 microdeletion: defining the critical region into a 0.8 M base interval.
    Kosaki K; Saito H; Kosaki R; Torii C; Kishi K; Takahashi T
    Am J Med Genet A; 2011 Sep; 155A(9):2212-4. PubMed ID: 21815246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malan syndrome: Extension of genotype and phenotype spectrum.
    Rai A; Narayanan DL; Phadke SR
    Am J Med Genet A; 2018 Dec; 176(12):2896-2900. PubMed ID: 30548146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletions in the 3' part of the NFIX gene including a recurrent Alu-mediated deletion of exon 6 and 7 account for previously unexplained cases of Marshall-Smith syndrome.
    Schanze D; Neubauer D; Cormier-Daire V; Delrue MA; Dieux-Coeslier A; Hasegawa T; Holmberg EE; Koenig R; Krueger G; Schanze I; Seemanova E; Shaw AC; Vogt J; Volleth M; Reis A; Meinecke P; Hennekam RC; Zenker M
    Hum Mutat; 2014 Sep; 35(9):1092-100. PubMed ID: 24924640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mutations of NFIX gene causing Marshall-Smith syndrome or Sotos-like syndrome: one gene, two phenotypes.
    Martinez F; Marín-Reina P; Sanchis-Calvo A; Perez-Aytés A; Oltra S; Roselló M; Mayo S; Monfort S; Pantoja J; Orellana C
    Pediatr Res; 2015 Nov; 78(5):533-9. PubMed ID: 26200704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable expressivity of Malan syndrome.
    Dutta AK
    BMJ Case Rep; 2024 Oct; 17(10):. PubMed ID: 39419602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malan syndrome: Sotos-like overgrowth with de novo NFIX sequence variants and deletions in six new patients and a review of the literature.
    Klaassens M; Morrogh D; Rosser EM; Jaffer F; Vreeburg M; Bok LA; Segboer T; van Belzen M; Quinlivan RM; Kumar A; Hurst JA; Scott RH
    Eur J Hum Genet; 2015 May; 23(5):610-5. PubMed ID: 25118028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel molecular mechanism in Malan syndrome uncovered through genome sequencing reanalysis, exon-level Array, and RNA sequencing.
    Zhao J; Longo N; Lewis RG; Nicholas TJ; Boyden SE; Andrews A; Larson A; ; Bayrak-Toydemir P; Botto LD; Mao R
    Am J Med Genet A; 2024 May; 194(5):e63516. PubMed ID: 38168088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A de novo 7.9 Mb deletion in 22q13.2→qter in a boy with autistic features, epilepsy, developmental delay, atopic dermatitis and abnormal immunological findings.
    Chen CP; Lin SP; Chern SR; Tsai FJ; Wu PC; Lee CC; Chen YT; Chen WL; Wang W
    Eur J Med Genet; 2010; 53(5):329-32. PubMed ID: 20541044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.